Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer

<div>The methylation patterns derived from MeDIP-seq datasets in lung cancer patients and controls. (a) Principal component analysis (PCA) of the methylation profiles of different populations examined. (b) The clustering analysis of the genome-wide methylation profiles in patients and controls.</div>

Disease Markers

fig1

Figure 1

Figure 1: Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer 